Article
The Centers for Medicare and Medicaid Services proposed an across-the-board 1.5% increase in payment rates for physicians caring for Medicare beneficiaries.
Real-world outcomes with nadofaragene point to safety, efficacy of NMIBC treatment
Episode 3 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management
Darolutamide plus ADT shows mHSPC benefit regardless of disease volume
Episode 2 Podcast: Identifying Patients with Intermediate Risk in NMIBC
Darolutamide is safe, efficacious in mHSPC regardless of patient age
Race subgroup analysis points to clinical benefit of darolutamide in nmCRPC